- Home
- EBMT vs NKTX Comparison
EBMT vs NKTX Comparison
Compare EBMT & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- NKTX
- Stock Information
- Founded
- EBMT 1922
- NKTX 2015
- Country
- EBMT United States
- NKTX United States
- Employees
- EBMT N/A
- NKTX N/A
- Industry
- EBMT Major Banks
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- EBMT Finance
- NKTX Health Care
- Exchange
- EBMT Nasdaq
- NKTX Nasdaq
- Market Cap
- EBMT 136.9M
- NKTX 123.5M
- IPO Year
- EBMT N/A
- NKTX 2020
- Fundamental
- Price
- EBMT $17.32
- NKTX $1.97
- Analyst Decision
- EBMT
- NKTX Strong Buy
- Analyst Count
- EBMT 0
- NKTX 5
- Target Price
- EBMT N/A
- NKTX $13.50
- AVG Volume (30 Days)
- EBMT 19.4K
- NKTX 539.6K
- Earning Date
- EBMT 10-28-2025
- NKTX 11-06-2025
- Dividend Yield
- EBMT 3.35%
- NKTX N/A
- EPS Growth
- EBMT 49.06
- NKTX N/A
- EPS
- EBMT 1.61
- NKTX N/A
- Revenue
- EBMT $84,696,000.00
- NKTX N/A
- Revenue This Year
- EBMT N/A
- NKTX N/A
- Revenue Next Year
- EBMT $5.20
- NKTX N/A
- P/E Ratio
- EBMT $10.76
- NKTX N/A
- Revenue Growth
- EBMT 5.13
- NKTX N/A
- 52 Week Low
- EBMT $14.35
- NKTX $1.31
- 52 Week High
- EBMT $18.49
- NKTX $6.49
- Technical
- Relative Strength Index (RSI)
- EBMT 54.35
- NKTX 41.11
- Support Level
- EBMT $17.19
- NKTX $2.00
- Resistance Level
- EBMT $17.68
- NKTX $2.08
- Average True Range (ATR)
- EBMT 0.31
- NKTX 0.11
- MACD
- EBMT -0.01
- NKTX -0.03
- Stochastic Oscillator
- EBMT 37.38
- NKTX 2.35
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.